Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)

Kalorama Information
January 1, 2012
160 Pages - SKU: KLI6490034
Research and Development In Biotechnology: State Industry Market Evaluator 541711
12/1/2014 | published by: BizMiner
Research and Development In Biotechnology: State Industry Market Evaluator 541711 This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics  |  read more...
USD 599
Medical Research: State Industry Market Evaluator 541711.04
12/1/2014 | published by: BizMiner
Medical Research: State Industry Market Evaluator 541711.04 This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for  |  read more...
USD 599
Transfusion & Transplantation Technologies - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary Transfusion & Transplantation Technologies (3Ti) is a diagnostic company. The company develops automated technology for the diagnostic testing of blood associated with blood transfusions. Its flagship product aegis blood analyzer and associated consumables is used  |  read more...
USD 750
Emesis (Vomiting) - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
Emesis (Vomiting) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Emesis (Vomiting) - Pipeline Review, H2 2014’, provides an overview of the Emesis (Vomiting)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Emesis  |  read more...
USD 2,000
Malignant Glioma - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
Malignant Glioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Glioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014’, provides an overview of the Transitional Cell Carcinoma (Urothelial Cell Carcinoma)’s  |  read more...
USD 2,000
Restenosis - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
Restenosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Restenosis - Pipeline Review, H2 2014’, provides an overview of the Restenosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Restenosis, complete with comparative  |  read more...
USD 2,000
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) - Pipeline Review, H2 2014’, provides an overview of the Nasopharyngitis (Common Cold)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Cedar Pollen Allergy - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
Cedar Pollen Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cedar Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Cedar Pollen Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Plague - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
Plague - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Plague - Pipeline Review, H2 2014’, provides an overview of the Plague’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Plague, complete with comparative  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 1,995  
    Global Site License  USD 3,990  
    Departmental Site License (one location, 10 users)  USD 2,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!